-
1
-
2
Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
Published 2020-01-01Get full text
Article -
3
Feasibility of Growth Factor Agent Therapy in Repairing Motor Injury
Published 2022-01-01Subjects: Get full text
Article -
4
Anti-tumor Necrosis Factor Agents and Tuberculosis in Inflammatory Bowel Disease
Published 2020-01-01Get full text
Article -
5
Promising novel treatment against keloids: Antivascular endothelial growth factor agents
Published 2019-01-01Get full text
Article -
6
Mid-Term Impact of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure
Published 2022-02-01Get full text
Article -
7
Risk for multidrug-resistant tuberculosis in patients treated with anti-tumor necrosis factor agents
Published 2023-03-01Get full text
Article -
8
Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium
Published 2023-05-01Get full text
Article -
9
Current perspectives on use of anti-vascular endothelial growth factor agents for retinal disorders
Published 2021-01-01Get full text
Article -
10
-
11
Retrospective cohort study of anti-tumor necrosis factor agent use in a veteran population
Published 2014-05-01Get full text
Article -
12
-
13
Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
Published 2017-02-01Get full text
Article -
14
-
15
-
16
-
17
-
18
-
19
-
20